Delivery Order SPE2DB22D3010-SPE2DB25FP3RJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a contract value of $5,593.77 and a completion date of October 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $22,375.12 under a firm fixed-price contract. This non-competitive delivery order, with an ultimate completion date of September 25, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical systems. The contract was performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $33,562.68, with completion scheduled for October 21, 2025. This non-set-aside award represents a competitive procurement action, consistent with AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical systems. The contract is performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Calquence 100 mg tablets in quantities of 60 units, with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was awarded through open competition without set-aside provisions. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $55,937.70 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Calquence 100 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, represents a non-set-aside competitive award to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. The contract falls under a child delivery order structure,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77 with a firm fixed price structure. The contract, issued without set-aside designation, demonstrates competitive award practices and carries an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $16,781.31. This firm fixed-price delivery order, which is not set-aside and represents a competitive award, is scheduled for ultimate completion by September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Calquence 100 mg tablets (60-unit quantity) under a firm fixed-price contract with a ceiling value of $5,593.77. This non-set-aside delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3RJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, valued at $5,593.77 with an ultimate completion date of October 21, 2025, represents a non-competitive, non-set-aside award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a key participant in DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/29/25 |